In order to examine these relationships, we used a well-characterised Wistar-Kyoto rat model (WKY72), which develops progressive tauopathy associated with significant body weight loss in parallel with the expression of pathological form of human tau protein [2,8,9]. The gene discussed is MAPT; the disease is tauopathy.